Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial

Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome

(2018) Alice Bonanni et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome

(2018) Josselin Bernard et al.   PEDIATRIC TRANSPLANTATION

Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome

(2018) Biswanath Basu et al.   JAMA Pediatrics

Ofatumumab for the treatment of childhood nephrotic syndrome

(2017) Chia-Shi Wang et al.   PEDIATRIC NEPHROLOGY

Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol

(2017) Pietro Ravani et al.   BMJ Open

Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab

(2016) Marina Vivarelli et al.   PEDIATRIC NEPHROLOGY

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children

(2015) P. Ravani et al.   Clinical Journal of the American Society of Nephrology

Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

(2015) P. Ravani et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

(2014) Kazumoto Iijima et al.   LANCET

Ofatumumab for Rituximab-Resistant Nephrotic Syndrome

(2014) Biswanath Basu   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome

(2013) Pietro Ravani et al.   KIDNEY INTERNATIONAL

Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome

(2012) A. Magnasco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial

(2011) P. Ravani et al.   Clinical Journal of the American Society of Nephrology

Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation

(2009) Luca Dello Strologo et al.   TRANSPLANTATION